Page 507 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Fluid, Electrolyte, and Acid-Base Disturbances in Liver Disease 495

73. Epstein M. Derangements of renal water handling in liver 93. Good DW. Effects of potassium on ammonia transport by
disease. Gastroenterology 1985;89:1415–25. medullary thick ascending limbs of the rat. J Clin Invest
74. Erlinger S. Physiology of bile secretion and enterohepatic 1987;80:1358–65.
circulation. In: Johnson LR, editor. Physiology of the gas- 94. Graf H, Leach W, Arieff AI. Metabolic effects of sodium
trointestinal tract. 2nd ed New York: Raven Press; 1987. bicarbonate in hypoxic lactic acidosis in dogs. Am J
p. 1557–80. Physiol 1985;249:F630–F635.
75. Evans TW. Review article: albumin as a drug: biological 95. Grauer GF, Pitts RP. Primary polydipsia in three dogs with
effects of albumin unrelated to oncotic pressure. Aliment portosystemic shunts. J Am Anim Hosp Assoc
Pharmacol Ther 2002;16(Suppl. 5):6–11. 1987;23:197–200.
76. Fassio E, Terg R, Landeira G, et al. Paracentesis with Dex- 96. Guzman JA, Rosado AE, Kruse JA. Vasopressin vs norepi-
tran 70 vs paracentesis with albumin in cirrhosis with tense nephrine in endotoxic shock: systemic, renal, and splanch-
ascites. Results of a randomized study. J Hepatol nic hemodynamic and oxygen transport effects. J Appl
1992;14:310–6. Physiol 2003;95:803–9.
77. Fenger-Eriksen C, Tonnesen E, Ingerslev J, et al. 97. Hartog C, Reinhart K. CONTRA: Hydroxyethyl starch
Mechanisms of hydroxyethyl starch-induced dilutional solutions are unsafe in critically ill patients. Intensive Care
coagulopathy. J Thromb Haemost 2009;7:1099–105. Med 2009;35:1337–42.
78. Fernandez-Varo G, Ros J, Cejudo-Martin P, et al. Effect of 98. Harvey JW, West CL. Prednisone-induced increases in
the V1a/V2-AVP receptor antagonist, Conivaptan, on serum alpha-2-globulin and haptoglobin concentrations
renal water metabolism and systemic hemodynamics in in dogs. Vet Pathol 1987;24:90–2.
rats with cirrhosis and ascites. J Hepatol 2003;38:755–61. 99. Haupt MT, Rackow EC. Colloid osmotic pressure and
79. Fink RM, Enns R, Kimball CP, et al. Plasma protein fluid resuscitation with hetastarch, albumin, and saline
metabolism: observations using heavy nitrogen in lysine. solutions. Crit Care Med 1982;10:159–62.
J Exp Med 1944;80:455–75. 100. Haussinger D, Kaiser S, Stehle T, et al. Liver carbonic
80. Flanders JA, Scarlett JM, Blue JT, et al. Adjustment of anhydrase and urea synthesis. The effect of diuretics.
total serum calcium concentration for binding to albumin Biochem Pharmacol 1986;35:3317–22.
and protein in cats: 291 cases (1986-1987). J Am Vet Med 101. Heinemann HO, Emirgil C, Mijnssen JP. Hyperventila-
Assoc 1989;194:1609–11. tion and arterial hypoxemia in cirrhosis of the liver. Am
81. Forrester SD, Moreland KJ. Hypophosphatemia: causes J Med 1960;28:239–46.
and clinical consequences. J Vet Intern Med 102. Heymsfield SB, Arteaga C, McManus C, et al. Measure-
1989;3:149–59. ment of muscle mass in humans: validity of the 24-hour
82. Foster KJ, Lin S, Turck CJ. Current and emerging urinary creatinine method. Am J Clin Nutr
strategies for treating hepatic encephalopathy. Crit Care 1983;37:478–94.
Nurs Clin North Am 2010;22:341–50. 103. Heymsfield SB, Waki M, Reinus J. Are patients with chronic
83. Francis AH, Martin LG, Haldorson GJ, et al. Adverse liver disease hypermetabolic? Hepatology 1990;11:502–4.
reactions suggestive of type III hypersensitivity in six 104. Hoffenberg R. Control of albumin degradation in vivo
healthy dogs given human albumin. J Am Vet Med Assoc and in the perfused liver. In: Rothschild MA,
2007;230:873–9. Waldmann T, editors. Plasma protein metabolism: regula-
84. Francisco LL, Sawin LL, Dibona GF. Mechanism of neg- tion of synthesis, distribution and degradation. New York:
ative potassium balance in the magnesium-deficient rat. Academic Press; 1970. p. 239–55.
Proc Soc Exp Biol Med 1981;168:382–8. 105. Holford AL, Tobias KM, Bartges JW, et al. Adrenal
85. Frommer JP. Lactic acidosis. Med Clin North Am response to adrenocorticotropic hormone in dogs before
1983;67:815–29. and after surgical attenuation of a single congenital
86. Fukuhara T, Ikegami T, Morita K, et al. Impact of portosystemic shunt. J Vet Intern Med 2008;22:832–8.
preoperative serum sodium concentration in living 106. Hulse J, Yacobi A. Hetastarch: an overview of the colloid
donor liver transplantation. J Gastroenterol Hepatol and its metabolism. Drug Intel Clin Pharmacol
2010;25:978–84. 1983;17:334–41.
87. Fukui H. Does angiotensin II typ. 1 receptor blockade 107. Jalan R, Kapoor D. Enhanced renal ammonia excretion
offer a clinical advantage to cirrhotics with ascites? J following volume expansion in patients with well
Gastroenterol 2002;37:235–7. compensated cirrhosis of the liver. Gut 2003;52:1041–5.
88. Garzon AA, Cheng C, Lerner B, et al. Hydroxyethyl starch 108. Jenq CC, Tsai MH, Tian YC, et al. Serum sodium predicts
(HES) and bleeding: an experimental investigation of its prognosis in critically ill cirrhotic patients. J Clin
effect on hemostasis. J Trauma 1967;7:757–66. Gastroenterol 2010;44:220–6.
89. Gerbes AL, Gulberg V, Gines P, et al. Therapy of 109. Jeunesse E, Woehrle F, Schneider M, et al. Spironolactone
hyponatremia in cirrhosis with a vasopressin receptor as a diuretic agent in the dog: is the water becoming
antagonist: a randomized double-blind multicenter trial. muddy (abstract). J Vet Intern Med 2004;18:448.
Gastroenterology 2003;124:933–9. 110. Kanno N, LeSage G, Glaser S, et al. Regulation of
90. Gines P, Berl T, Bernardi M, et al. Hyponatremia in cir- cholangiocyte bicarbonate secretion. Am J Physiol
rhosis: from pathogenesis to treatment. Hepatology 2001;281:G612–G625.
1998;28:851–64. 111. Karlson KE, Garzon AA, Shaftan GW, et al. Increased
91. Girgrah N, Liu P, Collier J, et al. Haemodynamic, renal blood loss associated with administration of certain
sodium handling, and neurohormonal effects of acute plasma expanders: Dextran 75, Dextran 40, and
administration of low dose losartan, an angiotensin II hydroxyethyl starch. Surgery 1967;62:670–8.
receptor antagonist, in preascitic cirrhosis. Gut 112. Kelly DA, Summerfield JA. Hemostasis in liver disease.
2000;46:114–20. Semin Liver Dis 1987;7:182–91.
92. Gollub S, Schaefer C, Squitieri A. The bleeding tendency 113. Kim JH, Lee JS, Lee SH, et al. The association between
associated with plasma expanders. Surg Gynecol Obstet the serum sodium level and the severity of complications
1967;124:1203–11. in liver cirrhosis. Korean J Intern Med 2009;24:106–12.